关键词：自身免疫性疾病；系统；攻击和破坏；体内健康组织；影响；神经系统
摘 要：Autoimmune diseases are immunological disorders that occur when the immune system attacks and destroys healthy tissues in the body rather than foreign bodies， causing significant pain, inflammation, and organ damage. These diseases can affect the nervous system, cardiovascular system, and musculoskeletal system or individual organs, including the skin, lungs, kidneys, glands, and joints.
目 录：

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

Top-vendor offerings

Assumptions

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Disease overview

Understanding the disease

Etiology

Signs and symptoms

Diagnosis

Management

Economic burden

Epidemiology

PART 06: Pipeline portfolio

PART 07: Market landscape

Market overview

Market size and forecast

Five forces analysis

PART 08: Market segmentation by type of disease

RA

MS

PsA

IBD

AS

SLE

Global RA drugs market

Clinical trials for RA

Global MS drugs market

Global PsA drugs market

Global IBD drugs market

Global AS drugs market

Global SLE drugs market

PART 09: Market segmentation by mechanism of action

TNF inhibitors

IL-1 blockers

COX inhibitors

PDE4 inhibitors

Others

PART 10: Market segmentation by drug class

DMARDs

NSAIDs

Corticosteroids

Analgesics

Immunosuppressants

Others

PART 11: Market segmentation by type of molecule

Biologics

Small molecules

PART 12: Market segmentation by ROA

Oral

Parenteral

Topical

PART 13: Market segmentation by dosage form

Solid

Liquid

Semi-solid

PART 14: Geographical segmentation

Autoimmune diseases drugs market in the Americas

Autoimmune diseases drugs market in US

Autoimmune diseases drugs market in EMEA

Autoimmune diseases drugs market in APAC

Autoimmune diseases drugs market in Japan

Autoimmune diseases drugs market in China

PART 15: Market drivers

Rising prevalence of autoimmune diseases

Growing older population

Dominance of biologics

Unmet medical needs

Promising pipeline

PART 16: Impact of drivers

PART 17: Market challenges

Increasing cost of biologics

Loss of patent exclusivity of branded therapies

Complex nature of autoimmune diseases

Preference for CAMs

Adverse effects

PART 18: Impact of drivers and challenges

PART 19: Market trends

Emergence of biosimilars

Patient assistance programs

Increase in public awareness programs

Strategic alliances

Popularity of off-label and traditional treatment options

PART 20: Vendor landscape

Competitive scenario

Market analysis 2015

AbbVie

Johnson & Johnson

Biogen

Amgen

Pfizer

F. Hoffmann-La Roche

Other prominent vendors

PART 21: Appendix

List of abbreviations

PART 22: Explore Technavio